A recent study confirms that frequent enterovirus infection may contribute to the development of type 1 diabetes in children.
The FDA's expanded indication for the Dexcom G5 Continuous Glucose Monitoring System allows for replacement of fingerstick glucose testing.
The risks of ischemic and hemorrhagic stroke are increased with type 1 diabetes, with incrementally increasing risks with increasing HbA1c.
The patient became severely hypoglycemic within 10 to 12 hours after taking the pain drug.
A standardized sliding scale insulin (SSI) order sheet can reduce the incidence of SSI-related medication errors.
For patients with type 1 diabetes, the incidence of hospitalization for hypoglycemia decreased over time in Denmark, with an 8.4% annual decrease.
For patients with type 1 diabetes, blood pressure (BP) of <120/70 mm Hg is associated with a substantially reduced risk of adverse renal outcomes.
For individuals with type 1 diabetes, liraglutide therapy does not affect the rate of gastric emptying during hypoglycemia.
Arsenic metabolism seems to be associated with type 1 diabetes in young people, with a potential interaction by folate levels.
Patients with type 1 diabetes diagnosed at age 15 to 27 years have low cumulative incidence of end-stage renal disease (ESRD) and increased mortality during long-term follow-up.
For patients with type 1 diabetes, the correlation between PCSK9 and LDL cholesterol is only seen in the highest tertile for HbA1c.
Low-carbohydrate diet results in lower incremental rises in plasma glucose after mild hypoglycemia.
Neonatal phototherapy is not associated with type 1 diabetes, according to a study published in Pediatrics.
Treated diabetic retinopathy is extremely rare among children with type 1 diabetes, according to research published in Diabetes Care.
Young adults with long-standing, childhood-onset type 1 diabetes have increased total and cardiovascular disease mortality.
Approval was based on a clinical trial that included 123 people with type 1 diabetes who used the MiniMed 670G hybrid closed-loop system for 3 months, after a 2-week period of no use.
A wide range in the rate of eGFR decline was observed per year.
Researchers assessed whether elevated FABP4 in early pregnancy could predict preeclampsia.
Metformin may help preserve cardiovascular health in patients with type 1 diabetes, according to a study published in Cardiovascular Diabetology.
Patients with type 1 diabetes have more diabetes-associated autoantibodies and non-diabetes-associated autoantibodies than patients with type 2 diabetes.
Smokers with type 1 diabetes have higher glycated hemoglobin and an unfavorable lipid profile.
Experimental study suggests repeated antibiotic exposure is associated with the development of type 1 diabetes.
For pregnant women with type 1 diabetes, closed-loop therapy is associated with a greater percentage of time that overnight glucose levels are in the target range.
Clinicians should consider a number of factors when weighing the risks and benefits of using SGLT2 inhibitors in patients with diabetes.
Liraglutide added to capped insulin is associated with reductions in glycated hemoglobin (HbA1c), body weight, and insulin requirements.
Glucagon should be recognized as a lifesaver for hypoglycemia and a major treatment for diabetes.
Patients with type 1 diabetes assigned to a 3-drug combination — dapagliflozin, liraglutide, and insulin — had superior blood glucose control compared with patients assigned to dapagliflozin monotherapy.
Higher baseline high-sensitivity C-reactive protein (hs-CRP) is associated with less treatment-linked improvement in depression in patients with type 1 diabetes.
C-peptide responses to mixed-meal tolerance tests are reliable surrogates of insulin secretion, according to a study published in Diabetes Care.